ArticleJournal of inflammation research2025
Biomarker Quantification of Gut Dysbiosis-Derived Inflammation: A Review.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association Between Blood-Brain Barrier Disruption and Gut Microbiota Dysbiosis in Parkinson's Disease.Cellular and molecular neurobiology · 2026Review
- "Unfolding Parkinson's Disease Through the Microbiome-Gut-Brain Axis".Journal of molecular neuroscience : MN · 2026Review
- Laminitis in Holstein dairy cows is associated with intestinal and mammary dysfunction, systemic inflammation, and microbiota dysregulation.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gut dysbiosis, an alteration or imbalance in the composition and function of the gut microbiome can lead to a range of health issues. Inflammation in this setting leads to increased permeability of the intestinal barrier and the activation of immune responses which contributes to a range of inflammatory, autoimmune and metabolic diseases. Therefore, precise quantification of gut-derived inflammation is important to gain insights into the development and progression these diseases and to develop treatments. This review highlights the underlying mechanisms leading to gut inflammation and the markers of gut dysbiosis mediated inflammation. We then discuss strategies including disposable and wearable biosensing devices, biomedical imaging, sequencing and AI-based methods for the quantification of dysbiosis-derived inflammation. Challenges and future perspectives for quantification of gut dysbiosis mediated inflammation are proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.